health

The presence and spread of new, more-infectious and immune-evading variants show that the coronavirus is not done mutating.

Acting through the microbiome, the fiber arabinoxylan reduces cholesterol in many people, while another fiber, called long-chain inulin, increases inflammation, a study finds.

Use of the drugs in children under the age of two was associated with lower antibody levels after the jabs—perhaps, researchers suggest, due to microbiome alterations.

Officials have ruled out known hepatitis viruses as the cause of a rash of illnesses in Europe and the US.

Observational evidence for the connection is solidifying, and some clues are emerging about the mechanisms that may explain it.

A new cohort study finds that boys whose fathers took the type 2 diabetes drug metformin three months before their conception were more likely to have a birth defect.

The patient, who has ALS, is able to communicate in complete sentences by deliberately altering his brain’s activity.

Unsatisfied by how treatments for childhood leukemia failed to prevent the disease’s return, Pinkel combined them all—and virtually cured the disease.

Malawi and its neighbors plan to vaccinate 9.4 million children against polio in the coming week to combat a suspected outbreak.

In Chapter 1, “Survival,” author Anna Machin describes the health benefits of strong human bonds.

He was among the first to identify lifestyle factors that contribute to cardiovascular disease.

Umbilical cord blood may be a good alternative to bone marrow transplants for treating HIV in patients with HIV and cancer.

Research in mice and flies suggests that bacteriophages, including those found in dairy foods, may have an influence on an animals’ ability to learn and remember information.

A study identifies a gene that appears to be partially responsible for the health effects of a limited diet.

Experts have a decent grasp on how COVID-19 impacts cardiovascular health in the near term. The implications of long COVID, however, remain mysterious.

Biomarkers in serum correlate with preeclampsia, a condition that can lead to fatal hypertension.

A preprint reports that the new SARS-CoV-2 variant multiplies faster in human bronchial tissue but slower in lung tissue than the Delta variant, potentially explaining how it’s spreading from person to person so quickly.